November 19, 2026 · Kidney international · DOI: 10.1016/j.kint.2026.09.020

Scaling human organoid models for drug discovery in polycystic kidney disease.

Listen to this summary

This commentary-style piece asks whether human kidney organoids can serve as a scalable, reproducible platform for drug discovery in polycystic kidney disease, given the variability and limited throughput of existing models. The authors (Vanichapol et al., as described by Combes) show that suspension culture of ureteric epithelium-like organoids with PKD2 loss produces rapid, highly penetrant cysts suitable for screening. The work also identifies Toll-like receptor 4 signaling as a candidate regulator of cyst growth and shows that epithelial identity and maturation state influence drug responses.

Alexander N Combes

This is one of 33,000+ journals available on OSLR. Try it free for 14 days.

Free 14-day trial. 33,000+ journals. Cancel anytime.

14-day free trial. No commitment.

“

"Oslr has become part of my weekly routine on my day off. The clinical relevance of the summaries is outstanding — I'd rate it 9/10. Being able to consume research hands-free is a huge advantage for busy physicians."

Dr. Jennifer Thompson

Dr. Jennifer Thompson

Portland, OR

Stay current without falling behind

33,000+ journals. 3-minute audio summaries. Free for 14 days.

Download on the App StoreGet it on Google Play